Membership
Tour
Register
Log in
Medicinal preparations containing organic active ingredients
Follow
Industry
CPC
A61K31/00
This industry / category may be too specific. Please go to a parent level for more data
Parent Industries
A
HUMAN NECESSITIES
A61
Medical science
A61K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Current Industry
A61K31/00
Medicinal preparations containing organic active ingredients
Sub Industries
A61K31/01
Hydrocarbons
A61K31/015
carbocyclic
A61K31/02
Halogenated hydrocarbons
A61K31/025
carbocyclic
A61K31/03
aromatic
A61K31/035
having aliphatic unsaturation
A61K31/04
Nitro compounds
A61K31/045
Hydroxy compounds
A61K31/047
having two or more hydroxy groups
A61K31/05
Phenols
A61K31/055
the aromatic ring being substituted by halogen
A61K31/06
the aromatic ring being substituted by nitro groups
A61K31/065
Diphenyl-substituted acyclic alcohols
A61K31/07
Retinol compounds
A61K31/075
Ethers or acetals
A61K31/08
acyclic
A61K31/085
having an ether linkage to aromatic ring nuclear carbon
A61K31/09
having two or more such linkages
A61K31/095
Sulfur, selenium, or tellurium compounds
A61K31/10
Sulfides Sulfoxides Sulfones
A61K31/105
Persulfides
A61K31/11
Aldehydes
A61K31/115
Formaldehyde
A61K31/12
Ketones
A61K31/121
acyclic
A61K31/122
having the oxygen directly attached to a ring
A61K31/125
Camphor Nuclear substituted derivatives thereof
A61K31/13
Amines
A61K31/131
acylic
A61K31/132
having two or more amino groups
A61K31/133
having hydroxy groups
A61K31/135
having aromatic rings
A61K31/136
having the amino group directly attached to the aromatic ring
A61K31/137
Arylalkylamines
A61K31/138
Aryloxyalkylamines
A61K31/14
Quaternary ammonium compounds
A61K31/145
having sulfur
A61K31/15
Oximes (>C=N-O-) Hydrazines (>N-N<) Hydrazones (>N-N=) Imines (C-N=C)
A61K31/155
Amidines ()
A61K31/16
Amides
A61K31/164
of a carboxlic acid with an aminoalcohol
A61K31/165
having aromatic rings
A61K31/166
having the carbon of a carboxamide group directly attached to the aromatic ring
A61K31/167
having the nitrogen of a carboxamide group directly attached to the aromatic ring
A61K31/17
having the group >N-C(O)-N< or >N-C(S)-N<
A61K31/175
having the group , >N-C(O)-N=N- or
A61K31/18
Sulfonamides
A61K31/185
Acids Anhydrides, halides or salts thereof
A61K31/19
Carboxylic acids
A61K31/191
having two or more hydroxy groups
A61K31/192
having aromatic groups
A61K31/194
having two or more carboxyl groups
A61K31/195
having an amino group
A61K31/196
the amino group being directly attached to a ring
A61K31/197
the amino and the carboxyl group being attached to the same acyclic carbon chain
A61K31/198
Alpha-aminoacids
A61K31/20
having a carboxyl group bound to a chain of seven or more carbon atoms
A61K31/201
having one or two double bonds
A61K31/202
having three or more double bonds
A61K31/203
Retinoic acids Salts thereof
A61K31/205
Amine addition salts of organic acids Inner quaternary ammonium salts
A61K31/21
Esters
A61K31/215
of carboxylic acids
A61K31/216
of acids having aromatic rings
A61K31/22
of acyclic acids
A61K31/221
with compounds having an amino group
A61K31/222
with compounds having aromatic groups
A61K31/223
of alpha-aminoacids
A61K31/225
Polycarboxylic acids
A61K31/23
of acids having a carboxyl group bound to a chain of seven or more carbon atoms
A61K31/231
having one or two double bonds
A61K31/232
having three or more double bonds
A61K31/235
having an aromatic ring attached to a carboxyl group
A61K31/24
having an amino or nitro group
A61K31/245
Amino benzoic acid types
A61K31/25
with polyoxyalkylated alcohols
A61K31/255
of sulfoxy acids or sulfur analogues thereof
A61K31/26
Cyanate or isoyanate esters Thiocyanate or isothiocyanate esters
A61K31/265
of carbonic, thiocarbonic, or thiocarboxylic acids
A61K31/27
of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
A61K31/275
Nitriles Isonitriles
A61K31/277
having a ring
A61K31/28
Compounds containing heavy metals
A61K31/282
Platinum compounds
A61K31/285
Arsenic compounds
A61K31/29
Antimony or bismuth compounds
A61K31/295
Iron group metal compounds
A61K31/30
Copper compounds
A61K31/305
Mercury compounds
A61K31/31
containing nitrogen
A61K31/315
Zinc compounds
A61K31/32
Tin compounds
A61K31/325
Carbamic acids Thiocarbamic acids Anhydrides or salts thereof
A61K31/327
Peroxy compounds
A61K31/33
Heterocyclic compounds
A61K31/335
having oxygen as the only ring hetero atom
A61K31/336
having three-membered rings
A61K31/337
having four-membered rings
A61K31/34
having five-membered rings with one oxygen as the only ring hetero atom
A61K31/341
not condensed with another ring
A61K31/343
condensed with a carbocyclic ring
A61K31/345
Nitrofurans
A61K31/35
having six-membered rings with one oxygen as the only ring hetero atom
A61K31/351
not condensed with another ring
A61K31/352
condensed with carbocyclic rings
A61K31/353
3,4-Dihydrobenzopyrans
A61K31/355
Tocopherols
A61K31/357
having two or more oxygen atoms in the same ring
A61K31/36
Compounds containing methylenedioxyphenyl groups
A61K31/365
Lactones
A61K31/366
having six-membered rings
A61K31/37
Coumarins
A61K31/375
Ascorbic acid
A61K31/38
having sulfur as a ring hetero atom
A61K31/381
having five-membered rings
A61K31/382
having six-membered rings
A61K31/385
having two or more sulfur atoms in the same ring
A61K31/39
having oxygen in the same ring
A61K31/395
having nitrogen as a ring hetero atom
A61K31/396
having thre-membered rings
A61K31/397
having four-membered rings
A61K31/40
having five-membered rings with one nitrogen as the only ring hetero atom
A61K31/401
Proline Derivatives thereof
A61K31/4015
having oxo groups directly attached to the heterocyclic ring
A61K31/402
1-aryl substituted
A61K31/4025
not condensed and containing further heterocyclic rings
A61K31/403
condensed with carbocyclic rings
A61K31/4035
Isoindoles
A61K31/404
Indoles
A61K31/4045
Indole-alkylamines Amides thereof
A61K31/405
Indole-alkanecarboxylic acids Derivatives thereof
A61K31/407
condensed with other heterocyclic ring systems
A61K31/409
having four such rings
A61K31/41
having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen
A61K31/415
1,2-Diazoles
A61K31/4152
having oxo groups directly attached to the heterocyclic ring
A61K31/4155
non condensed and containing further heterocyclic rings
A61K31/416
condensed with carbocyclic ring systems
A61K31/4162
condensed with heterocyclic ring systems
A61K31/4164
1,3-Diazoles
A61K31/4166
having oxo groups directly attached to the heterocyclic ring
A61K31/4168
having a nitrogen attached in position 2
A61K31/417
Imidazole-alkylamines
A61K31/4172
Imidazole-alkanecarboxylic acids
A61K31/4174
Arylalkylimidazoles
A61K31/4178
not condensed 1,3-diazoles and containing further heterocyclic rings
A61K31/4184
condensed with carbocyclic rings
A61K31/4188
condensed with other heterocyclic ring systems
A61K31/4192
1,2,3-Triazoles
A61K31/4196
1,2,4-Triazoles
A61K31/42
Oxazoles
A61K31/421
1,3-Oxazoles
A61K31/422
not condensed and containing further heterocyclic rings
A61K31/423
condensed with carbocyclic rings
A61K31/424
condensed with heterocyclic ring systems
A61K31/4245
Oxadiazoles
A61K31/425
Thiazoles
A61K31/426
1,3-Thiazoles
A61K31/427
not condensed and containing further heterocyclic rings
A61K31/428
condensed with carbocyclic rings
A61K31/429
condensed with heterocyclic ring systems
A61K31/43
Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula
A61K31/431
containing further heterocyclic rings
A61K31/433
Thidiazoles
A61K31/435
having six-membered rings with one nitrogen as the only ring hetero atom
A61K31/4353
ortho- or peri-condensed with heterocyclic ring systems
A61K31/4355
the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
A61K31/436
the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e..g. rapamycin
A61K31/4365
the heterocyclic ring system having sulfur as a ring hetero atom
A61K31/437
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom
A61K31/4375
the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom
A61K31/438
the ring being spiro-condensed with carbocyclic ring systems
A61K31/439
the ring forming part of a bridged ring system
A61K31/44
Non condensed pyridines Hydrogenated derivatives thereof
A61K31/4402
only substituted in position 2
A61K31/4406
only substituted in position 3
A61K31/4409
only substituted in position 4
A61K31/4412
having oxo groups directly attached to the heterocyclic ring
A61K31/4415
Pyridoxine
A61K31/4418
having a carbocyclic group directly attached to the heterocyclic ring
A61K31/4422
1,4-Dihydropyridines
A61K31/4425
Pyridinium derivatives
A61K31/4427
containing further heterocyclic ring systems
A61K31/443
containing a five-membered ring with oxygen as a ring hetero atom
A61K31/4433
containing a six-membered ring with oxygen as a ring hetero atom
A61K31/4436
containing a heterocyclic ring having sulfur as a ring hetero atom
A61K31/4439
containing a five-membered ring with nitrogen as a ring hetero atom
A61K31/444
containing a six-membered ring with nitrogen as a ring heteroatom
A61K31/445
Non condensed piperidines
A61K31/4453
only substituted in position 1
A61K31/4458
only substituted in position 2
A61K31/4462
only substituted in position 3
A61K31/4465
only substituted in position 4
A61K31/4468
having a nitrogen directly attached in position 4
A61K31/45
having oxo groups directly attached to the heterocyclic ring
A61K31/451
having a carbocyclic group directly attached to the heterocyclic ring
A61K31/4515
having a butyrophenone group in position 1
A61K31/452
Piperidinium derivatives
A61K31/4523
containing further heterocyclic ring systems
A61K31/4525
containing a five-membered ring with oxygen as a ring hetero atom
A61K31/453
containing a six-membered ring with oxygen as a ring hetero atom
A61K31/4535
containing a heterocyclic ring having sulfur as a ring hetero atom
A61K31/454
containing a five-membered ring with nitrogen as a ring hetero atom
A61K31/4545
containing a six-membered ring with nitrogen as a ring hetero atom
A61K31/455
Nicotinic acids
A61K31/46
8-Azabicyclo [3.2.1] octane Derivatives thereof
A61K31/465
Nicotine Derivatives thereof
A61K31/47
Quinolines Isoquinolines
A61K31/4704
2-Quinolinones
A61K31/4706
4-Aminoquinolines 8-Aminoquinolines
A61K31/4709
Non-condensed quinolines and containing further heterocyclic rings
A61K31/472
Non-condensed isoquinolines
A61K31/4725
containing further heterocyclic rings
A61K31/473
ortho- or peri-condensed with carbocyclic ring systems
A61K31/4738
ortho- or peri-condensed with heterocyclic ring systems
A61K31/4741
condensed with ring systems having oxygen as a ring hetero atom
A61K31/4743
condensed with ring systems having sulfur as a ring hetero atom
A61K31/4745
condensed with ring systems having nitrogen as a ring hetero atom
A61K31/4747
Spiro-condensed
A61K31/4748
forming part of bridged ring systems
A61K31/475
having an indole ring
A61K31/48
Ergoline derivatives
A61K31/485
Morphinan derivatives
A61K31/49
Cinchonan derivatives
A61K31/495
having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms
A61K31/496
Non-condensed piperazines containing further heterocyclic rings
A61K31/4965
Non-condensed pyrazines
A61K31/497
containing further heterocyclic rings
A61K31/498
Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems
A61K31/4985
Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A61K31/499
Spiro-condensed pyrazines or piperazines
A61K31/4995
Pyrazines or piperazines forming part of bridged ring systems
A61K31/50
Pyridazines Hydrogenated pyridazines
A61K31/501
not condensed and containing further heterocyclic rings
A61K31/502
ortho- or peri-condensed with carbocyclic ring systems
A61K31/5025
ortho- or peri-condensed with heterocyclic ring systems
A61K31/503
spiro-condensed
A61K31/504
forming part of bridged ring systems
A61K31/505
Pyrimidines Hydrogenated pyrimidines
A61K31/506
not condensed and containing further heterocyclic rings
A61K31/51
Thiamines
A61K31/513
having oxo groups directly attached to the heterocyclic ring
A61K31/515
Barbituric acids Derivatives thereof
A61K31/517
ortho- or peri-condensed with carbocyclic ring systems
A61K31/519
ortho- or peri-condensed with heterocyclic rings
A61K31/52
Purines
A61K31/522
having oxo groups directly attached to the heterocyclic ring
A61K31/525
Isoalloxazines
A61K31/527
spiro-condensed
A61K31/529
forming part of bridged ring systems
A61K31/53
having six-membered rings with three nitrogens as the only ring hetero atoms
A61K31/535
having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms
A61K31/5355
non-condensed oxazines and containing further heterocyclic rings
A61K31/536
ortho- or peri-condensed with carbocyclic ring systems
A61K31/5365
ortho- or peri-condensed with heterocyclic ring systems
A61K31/537
spiro-condensed or forming part of bridged ring systems
A61K31/5375
1,4-Oxazines
A61K31/5377
not condensed and containing further heterocyclic rings
A61K31/538
ortho- or peri-condensed with carbocyclic ring systems
A61K31/5383
ortho- or peri-condensed with heterocyclic ring systems
A61K31/5386
Spiro-condensed or forming part of bridged ring systems
A61K31/539
having two or more oxygen atoms in the same ring
A61K31/5395
having two or more nitrogen atoms in the same ring
A61K31/54
having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms
A61K31/541
non-condensed thiazines containing further heterocyclic rings
A61K31/5415
ortho- or peri-condensed with carbocyclic ring systems
A61K31/542
ortho- or peri-condensed with heterocyclic ring systems
A61K31/545
Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
A61K31/546
containing further heterocyclic rings
A61K31/547
spiro-condensed or forming part of bridged ring systems
A61K31/548
having two or more sulfur atoms in the same ring
A61K31/549
having two or more nitrogen atoms in the same ring
A61K31/55
having seven-membered rings
A61K31/551
having two nitrogen atoms
A61K31/5513
1,4-Benzodiazepines
A61K31/5517
condensed with five-membered rings having nitrogen as a ring hetero atom
A61K31/553
having at least one nitrogen and one oxygen as ring hetero atoms
A61K31/554
having at least one nitrogen and one sulfur as ring hetero atoms
A61K31/555
containing heavy metals
A61K31/557
Eicosanoids
A61K31/5575
having a cyclopentane
A61K31/5578
having a pentalene ring system
A61K31/558
having heterocyclic rings containing oxygen as the only ring hetero atom
A61K31/5585
having five-membered rings containing oxygen as the only ring hetero atom
A61K31/559
having heterocyclic rings containing hetero atoms other than oxygen
A61K31/56
Compounds containing cyclopenta[a]hydrophenanthrene ring systems Derivatives
A61K31/565
not substituted in position 17 beta by a carbon atom
A61K31/566
having an oxo group in position 17
A61K31/567
substituted in position 17 alpha
A61K31/568
substituted in positions 10 and 13 by a chain having at least one carbon atom
A61K31/5685
having an oxo group in position 17
A61K31/569
substituted in position 17 alpha
A61K31/57
substituted in position 17 beta by a chain of two carbon atoms
A61K31/573
substituted in position 21
A61K31/575
substituted in position 17 beta by a chain of three or more carbon atoms
A61K31/58
containing heterocyclic rings
A61K31/585
containing lactone rings
A61K31/59
Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
A61K31/592
9,10-Secoergostane derivatives, e.g. ergocalciferol
A61K31/593
9,10-Secocholestane derivatives, e.g. cholecalciferol
A61K31/60
Salicylic acid Derivatives thereof
A61K31/603
having further aromatic rings
A61K31/606
having amino groups
A61K31/609
Amides
A61K31/612
having the hydroxy group in position 2 esterified
A61K31/616
by carboxylic acids
A61K31/618
having the carboxyl group in position 1 esterified
A61K31/621
having the hydroxy group in position 2 esterified
A61K31/625
having heterocyclic substituents
A61K31/63
Compounds containing para-N-benzenesulfonyl-N-groups
A61K31/635
having a heterocyclic ring
A61K31/64
Sulfonylureas
A61K31/65
Tetracyclines
A61K31/655
Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
A61K31/66
Phosphorus compounds
A61K31/661
Phosphorus acids or esters thereof not having P-C bonds
A61K31/6615
Compounds having two or more esterified phosphorus acid groups
A61K31/662
Phosphorus acids or esters thereof having P-C bonds
A61K31/663
Compounds having two or more phosphorus acid groups or esters thereof
A61K31/664
Amides of phosphorus acids
A61K31/665
having oxygen as a ring hetero atom
A61K31/67
having sulfur as a ring hetero atom
A61K31/675
having nitrogen as a ring hetero atom
A61K31/683
Diesters of a phosphorus acid with two hydroxy compounds
A61K31/685
one of the hydroxy compounds having nitrogen atoms
A61K31/688
both hydroxy compounds having nitrogen atoms
A61K31/69
Boron compounds
A61K31/695
Silicon compounds
A61K31/70
Carbohydrates Sugars Derivatives thereof
A61K31/7004
Monosaccharide having only carbon, hydrogen and oxygen atoms
A61K31/7008
Compounds having an amino group directly attached to a carbon atom of the saccharide radical
A61K31/7012
Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical
A61K31/7016
Disaccharides
A61K31/702
Oligosaccharides
A61K31/7024
Esters of saccharides
A61K31/7028
Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
A61K31/7032
attached to a polyol, i.e. compound having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage
A61K31/7034
attached to a carbocyclic compound
A61K31/7036
having at least one amino group directly attached to the carbocyclic ring
A61K31/704
attached to a condensed carbocyclic ring system
A61K31/7042
Compounds having saccharide radicals and heterocyclic rings
A61K31/7048
having oxygen as a ring hetero atom
A61K31/7052
having nitrogen as a ring hetero atom
A61K31/7056
containing five-membered rings with nitrogen as a ring hetero atom
A61K31/706
containing six-membered rings with nitrogen as a ring hetero atom
A61K31/7064
containing condensed or non-condensed pyrimidines
A61K31/7068
having oxo groups directly attached to the pyrimidine ring
A61K31/7072
having two oxo groups directly attached to the pyrimidine ring
A61K31/7076
containing purines
A61K31/708
having oxo groups directly attached to the purine ring system
A61K31/7084
Compounds having two nucleosides or nucleotides
A61K31/7088
Compounds having three or more nucleosides or nucleotides
A61K31/7105
Natural ribonucleic acids
A61K31/711
Natural deoxyribonucleic acids
A61K31/7115
Nucleic acids or oligonucleotides having modified bases
A61K31/712
Nucleic acids or oligonucleotides having modified sugars
A61K31/7125
Nucleic acids or oligonucleotides having modified internucleoside linkage
A61K31/713
Double-stranded nucleic acids or oligonucleotides
A61K31/7135
Compounds containing heavy metals
A61K31/714
Cobalamins, e.g. cyanocobalamin
A61K31/715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages Derivatives thereof
A61K31/716
Glucans
A61K31/717
Celluloses
A61K31/718
Starch or degraded starch
A61K31/719
Pullulans
A61K31/721
Dextrans
A61K31/722
Chitin, chitosan
A61K31/723
Xanthans
A61K31/724
Cyclodextrins
A61K31/726
Glycosaminoglycans
A61K31/727
Heparin Heparan
A61K31/728
Hyaluronic acid
A61K31/729
Agar Agarose Agaropectin
A61K31/731
Carrageenans
A61K31/732
Pectin
A61K31/733
Fructosans
A61K31/734
Alginic acid
A61K31/736
Glucomannans or galactomannans
A61K31/737
Sulfated polysaccharides
A61K31/738
Cross-linked polysaccharides
A61K31/739
Lipopolysaccharides
A61K31/74
Synthetic polymeric materials
A61K31/745
Polymers of hydrocarbons
A61K31/75
of ethene
A61K31/755
Polymers containing halogen
A61K31/76
of vinyl chloride
A61K31/765
Polymers containing oxygen
A61K31/77
of oxiranes
A61K31/775
Phenolic resins
A61K31/78
of acrylic acid or derivatives thereof
A61K31/785
Polymers containing nitrogen
A61K31/787
containing heterocyclic rings having nitrogen as a ring hetero atom
A61K31/79
Polymers of vinyl pyrrolidone
A61K31/795
Polymers containing sulfur
A61K31/80
Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
Industries
Overview
Organizations
People
Information
Impact
Please log in for detailed analytics
Patents Grants
last 30 patents
Information
Patent Grant
Inhibitory effect of low molecular weight compound on cancer and fi...
Patent number
12,303,510
Issue date
May 20, 2025
National University Corporation Tottori University
Goshi Shiota
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Combination therapy of cycloserine and lithium for the treatment of...
Patent number
12,303,530
Issue date
May 20, 2025
NEURORIVE INC
Sukchan Lee
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Erodium crassifolium L'Her plant extracts and uses thereof
Patent number
12,303,541
Issue date
May 20, 2025
The State of Israel, Ministry of Agriculture & Rural Development, Agricultura...
Hinanit Koltai
A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information
Patent Grant
Specific conjugation linkers, specific immunoconjugates thereof, me...
Patent number
12,303,571
Issue date
May 20, 2025
HANGZHOU DAC BIOTECH CO., LTD.
Robert Yongxin Zhao
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Naloxone formulations for sublingual and/or buccal administration
Patent number
12,303,597
Issue date
May 20, 2025
PHARMACEUTICAL PRODUCTIONS, INC.
John A. McCarty
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Self-emulsifying cannabidiol formulations
Patent number
12,303,599
Issue date
May 20, 2025
Benuvia Operations, LLC
Kiran Kumar Vangara
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods and compositions for modifying mucous membranes
Patent number
12,303,607
Issue date
May 20, 2025
Nicholas L. Abbott
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
BBB-crossing lipid ligand of hetero nucleic acid
Patent number
12,305,169
Issue date
May 20, 2025
National University Corporation Tokyo Medical and Dental University
Takanori Yokota
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
S-enantiomerically enriched compositions of beta blockers for treat...
Patent number
12,303,474
Issue date
May 20, 2025
Actimed Therapeutics Limited
Andrew J.S. Coats
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Lipase degradation resistant surfactants for use in large molecule...
Patent number
12,303,483
Issue date
May 20, 2025
Janssen Biotech, Inc.
Steven LaBrenz
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
N-acylated fatty amino acids to reduce absorption variability in ca...
Patent number
12,303,487
Issue date
May 20, 2025
Spoke Sciences, Inc.
Andrea Leone-Bay
A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information
Patent Grant
Compositions and methods for monitoring, diagnosis, prognosis, dete...
Patent number
12,303,494
Issue date
May 20, 2025
GLAX Health LLC
Shivani Shrivastava
G01 - MEASURING TESTING
Information
Patent Grant
ALK5 inhibitors as skeletal muscle hypertrophy inducers
Patent number
12,303,498
Issue date
May 20, 2025
CYTOO
Pauline Poydenot
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Use of dextromethorphan in combination with CYP2D6 and CYP3A4 enzym...
Patent number
12,303,503
Issue date
May 20, 2025
BIOBINA LLC
Robert Taub
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Compounds for the treatment of BRAF-associated diseases and disorders
Patent number
12,303,509
Issue date
May 20, 2025
Pfizer Inc.
Patrick Michael Doerner Barbour
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Application of aspartic acid derivative in preparing animal feed ad...
Patent number
12,302,927
Issue date
May 20, 2025
ANIPHA TECHNOLOGIES PTY LTD
Xianfeng Peng
A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information
Patent Grant
HIV treatment compositions and methods
Patent number
12,303,477
Issue date
May 20, 2025
NantCell, Inc.
Kayvan Niazi
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Method of treating cancer
Patent number
12,303,484
Issue date
May 20, 2025
University of Louisiana at Lafayette
Radhey Srivastava
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Treating iron deficiency with ferric carboxymaltose
Patent number
12,303,486
Issue date
May 20, 2025
Pharmacosmos Holding A/S
Tobias Sidelmann Christensen
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Combination treatment of arthritic disease
Patent number
12,303,489
Issue date
May 20, 2025
Synact Pharma APS
Thomas Engelbrecht Nordkild Jonassen
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Anticancer compositions
Patent number
12,303,493
Issue date
May 20, 2025
Aragon Pharmaceuticals, Inc.
Dennis Martin Hester
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Anti-androgens for the treatment of metastatic castration-sensitive...
Patent number
12,303,497
Issue date
May 20, 2025
Aragon Pharmaceuticals, Inc.
Margaret K. Yu
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Tumor-treating pharmaceutical composition
Patent number
12,303,505
Issue date
May 20, 2025
Eisai R&D Management Co., Ltd.
Yoichi Ozawa
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods related to opioid therapeutics
Patent number
12,303,511
Issue date
May 20, 2025
University of Florida Research Foundation, Incorporated
Kirill Martemyanov
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Oral testosterone therapy
Patent number
12,303,517
Issue date
May 20, 2025
Nachiappan Chidambaram
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Method for treating dupuytren's disease
Patent number
12,303,523
Issue date
May 20, 2025
DALE BIOTECH, LLC
Anton Leighton
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for tre...
Patent number
12,303,525
Issue date
May 20, 2025
Hoffman-La Roche Inc.
Susanne Kammler
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
High molecular weight hyaluronic acid for treatment and prevention...
Patent number
12,303,527
Issue date
May 20, 2025
I.COM MEDICAL GMBH
Wolfgang Georg Konrad Müller-Lierheim
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Storage stable formulations of sulfated glycosaminoglycans and frag...
Patent number
12,303,528
Issue date
May 20, 2025
ADORA ANIMAL HEALTH CORPORATION
Thomas Michael Vaughn
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Pharmaceutical composition comprising mesenchymal stem cells as eff...
Patent number
12,303,534
Issue date
May 20, 2025
MEDIPOST CO., LTD
Yun Sun Yang
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Patents Applications
last 30 patents
Information
Patent Application
ENDOVASCULAR INTERVENTIONS IN NEUROVASCULAR ANATOMY
Publication number
20250160843
Publication date
May 22, 2025
Route 92 Medical, Inc.
Tony M. Chou
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
ORAL PRODUCTS, THREE-DIMENSIONAL PRINTERS USED FOR FORMING ORAL PRO...
Publication number
20250161207
Publication date
May 22, 2025
Altria Client Services LLC
Eve MARIN
B33 - ADDITIVE MANUFACTURING TECHNOLOGY
Information
Patent Application
Orally Adhering Lozenges Containing Soluble Dietary Fiber
Publication number
20250161208
Publication date
May 22, 2025
Quest Products, LLC
Jeffrey Haley
A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information
Patent Application
SYSTEM AND METHOD FOR AEROBIC RESPIRATORY TREATMENT
Publication number
20250161209
Publication date
May 22, 2025
Jeff Braile
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PHARMACEUTICAL FORMULATION
Publication number
20250161223
Publication date
May 22, 2025
Novartis AG
Bindhumadhavan GURURAJAN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CYSTEAMIDES, THERAPEUTIC COMPOSITIONS THEREOF, AND RELATED METHODS
Publication number
20250161241
Publication date
May 22, 2025
Boyce Thompson Institute for Plant Research, Inc.
Frank C. Schroeder
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
MEF2 TRANSCRIPTIONAL ACTIVATORS TO TREAT NEUROLOGIC CONDITIONS
Publication number
20250161243
Publication date
May 22, 2025
The Scripps Research Institute
Stuart Lipton
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PREPARATION METHOD AND USE OF LIPOSOME ENCAPSULATING POLYPEPTIDE, S...
Publication number
20250161244
Publication date
May 22, 2025
UNION HOSPITAL, TONGJI MEDICAL COLLEGE, HUAZHONG UNI. OF SCIENCE AND TECH.
Huikuan CHU
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Treating Chronic Myelomonocytic Leukemia with CXCL8 Receptor Inhibi...
Publication number
20250161248
Publication date
May 22, 2025
INSTITUT GUSTAVE ROUSSY
Dorothee SELIMOGLU-BUET
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
IMMUNOSUPPRESSIVE COMPOSITION CONTAINING L-AHG
Publication number
20250161337
Publication date
May 22, 2025
Kyungpook National University Industry-Academic Cooperation Foundation
Young Ho Kim
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Compounds for Anti-aging Intervention
Publication number
20250161338
Publication date
May 22, 2025
Agency for Science, Technology and Research
Mohammad Alfatah
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON...
Publication number
20250161344
Publication date
May 22, 2025
Avidity Biosciences, Inc.
Arthur A. LEVIN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PROCESS FOR PREPARATION OF COMPOSITIONS OF OLIGOMERS OF LACTIC ACID
Publication number
20250161348
Publication date
May 22, 2025
Combe Incorporated
Gabriella YOUSEF
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CANCER TREATMENT BY ARSENIC TRIOXIDE COMBINATION THERAPY
Publication number
20250161351
Publication date
May 22, 2025
Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
Andreas TRUMPP
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
UROLITHIN COMBINATION
Publication number
20250161391
Publication date
May 22, 2025
AMAZENTIS SA
Christopher L. Rinsch
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITION AND METHOD FOR IMPROVING LIPID METABOLISM FUNCTION OF S...
Publication number
20250161396
Publication date
May 22, 2025
Nanjing Nutrabuilding Bio-tech Co., Ltd.
Rui SHU
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE
Publication number
20250161402
Publication date
May 22, 2025
Schepens Eye Research Institute
Reza Dana
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITIONS AND METHODS FOR TREATMENT OF IDIOPATHIC PULMONARY FIBR...
Publication number
20250161250
Publication date
May 22, 2025
NUFORMIX TECHNOLOGIES LIMITED
Joanne HOLLAND
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
NUTRITIONAL PRODUCT
Publication number
20250161253
Publication date
May 22, 2025
VITAFLO (INTERNATIONAL) LTD
Maura O'Donnell
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
NEW THERAPY AND PREVENTION FOR SUPPRESSING AGING-RELATED DISORDERS...
Publication number
20250161255
Publication date
May 22, 2025
Motoshi HAYANO
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
USE OF DELTA-TOCOTRIENOL TO REDUCE THE PROGRESSION OF A NEOPLASM TO...
Publication number
20250161260
Publication date
May 22, 2025
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Mokenge MALAFA
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Pharmaceutical Compositions and Methods for Treating Covid
Publication number
20250161262
Publication date
May 22, 2025
Steven Baranowitz
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY
Publication number
20250161268
Publication date
May 22, 2025
Mind Medicine, Inc.
Robert BARROW
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
EXATECAN FORMULATION
Publication number
20250161295
Publication date
May 22, 2025
Yale University
Michael Girardi
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITIONS AND METHODS FOR INHIBITING FSP1
Publication number
20250161297
Publication date
May 22, 2025
The Regents of the University of California
James Arthur Olzmann
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Methods for Treating Cancer Using Pyrimidine and Pyridine Compounds...
Publication number
20250161304
Publication date
May 22, 2025
Merck Patent GmbH
Bayard R. HUCK
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS FOR THE...
Publication number
20250161306
Publication date
May 22, 2025
KSQ Therapeutics, Inc.
Andrew Alistair WYLIE
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
USE OF HPK1 INHIBITOR IN TREATMENT OF INTERFERON-RELATED DISEASES
Publication number
20250161319
Publication date
May 22, 2025
ASCLEPIEION PHARMACEUTICAL CO., LTD
Wenjuan WEI
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
AMINO ACID BASED CARBAMATES AND/OR UREAS FOR THE TREATMENT OF SORTI...
Publication number
20250161321
Publication date
May 22, 2025
Vesper Bio ApS
Manuel Javier CASES-THOMAS
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
FORMULATION OF LONG-ACTING LEVONORGESTREL BUTANOATE INJECTABLE DEPO...
Publication number
20250161323
Publication date
May 22, 2025
Eastern Virginia Medical School
Timothy J. MCCORMICK
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE